A Study of the Safety of REN001 in Patients With McArdle Disease
NCT04226274
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
McArdle Disease
Interventions
DRUG:
REN001
Sponsor
Reneo Pharma Ltd